Does the media favor KSPI or LIF?

In the previous week, Life360 had 9 more articles in the media than Joint Stock Company Kaspi.kz. MarketBeat recorded 11 mentions for Life360 and 2 mentions for Joint Stock Company Kaspi.kz. Joint Stock Company Kaspi.kz's average media sentiment score of 0.93 beat Life360's score of 0.44 indicating that Joint Stock Company Kaspi.kz is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Joint Stock Company Kaspi.kz 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Life360 2 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings and valuation, LIF or MEDP?

Medpace has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Life360 $489.48M 9.14 $150.83M $1.73 31.93 Medpace $2.53B 6.05 $451.12M $15.91 33.71

Is LIF or MEDP more profitable?

Life360 has a net margin of 28.21% compared to Medpace's net margin of 17.19%. Medpace's return on equity of 120.89% beat Life360's return on equity. Company Net Margins Return on Equity Return on Assets Life360 28.21% 6.80% 3.65% Medpace 17.19% 120.89% 24.79%

Does the media refer more to LIF or MEDP?

In the previous week, Life360 had 8 more articles in the media than Medpace. MarketBeat recorded 11 mentions for Life360 and 3 mentions for Medpace. Medpace's average media sentiment score of 0.98 beat Life360's score of 0.44 indicating that Medpace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Life360 2 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Medpace 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, RTO or LIF?

Rentokil Initial has higher revenue and earnings than Life360. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Rentokil Initial $6.91B 2.08 $470M N/A N/A Life360 $489.48M 9.14 $150.83M $1.73 31.93

Which has stronger valuation and earnings, GRAB or LIF?

Grab has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Grab, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Grab $3.37B 4.69 $268M $0.01 385.50 Life360 $489.48M 9.14 $150.83M $1.73 31.93

Is GRAB or LIF more profitable?

Life360 has a net margin of 28.21% compared to Grab's net margin of 10.67%. Life360's return on equity of 6.80% beat Grab's return on equity. Company Net Margins Return on Equity Return on Assets Grab 10.67% 5.79% 3.28% Life360 28.21% 6.80% 3.65%

Does the media favor GRAB or LIF?

In the previous week, Grab had 2 more articles in the media than Life360. MarketBeat recorded 13 mentions for Grab and 11 mentions for Life360. Grab's average media sentiment score of 0.63 beat Life360's score of 0.44 indicating that Grab is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Grab 5 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Life360 2 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, TOST or LIF?

Toast has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Toast, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Toast $6.45B 2.26 $342M $0.65 43.50 Life360 $489.48M 9.14 $150.83M $1.73 31.93

Is TOST or LIF more profitable?

Life360 has a net margin of 28.21% compared to Toast's net margin of 6.39%. Toast's return on equity of 20.86% beat Life360's return on equity. Company Net Margins Return on Equity Return on Assets Toast 6.39% 20.86% 13.84% Life360 28.21% 6.80% 3.65%

Does the media refer more to TOST or LIF?

In the previous week, Life360 had 6 more articles in the media than Toast. MarketBeat recorded 11 mentions for Life360 and 5 mentions for Toast. Life360's average media sentiment score of 0.44 beat Toast's score of 0.42 indicating that Life360 is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Toast 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Life360 2 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Life360 (LIF) Competitors

$55.56 -2.03 (-3.52%)

As of 01:38 PM Eastern

Compare

LIF vs. KSPI, MEDP, RTO, GRAB, and TOST

Should you buy Life360 stock or one of its competitors? MarketBeat compares Life360 with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Life360 include Joint Stock Company Kaspi.kz (KSPI), Medpace (MEDP), Rentokil Initial (RTO), Grab (GRAB), and Toast (TOST). These companies are all part of the "business services" industry.

How does Life360 compare to Joint Stock Company Kaspi.kz?

Joint Stock Company Kaspi.kz (NASDAQ:KSPI) and Life360 (NASDAQ:LIF) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Joint Stock Company Kaspi.kz has higher revenue and earnings than Life360. Joint Stock Company Kaspi.kz is trading at a lower price-to-earnings ratio than Life360, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Joint Stock Company Kaspi.kz	$7.70B	2.13	$2.04B	$10.84	7.97
Life360	$489.48M	9.14	$150.83M	$1.73	31.93

In the previous week, Life360 had 9 more articles in the media than Joint Stock Company Kaspi.kz. MarketBeat recorded 11 mentions for Life360 and 2 mentions for Joint Stock Company Kaspi.kz. Joint Stock Company Kaspi.kz's average media sentiment score of 0.93 beat Life360's score of 0.44 indicating that Joint Stock Company Kaspi.kz is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Joint Stock Company Kaspi.kz	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Life360	2 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Joint Stock Company Kaspi.kz presently has a consensus target price of $96.67, indicating a potential upside of 11.84%. Life360 has a consensus target price of $64.17, indicating a potential upside of 16.16%. Given Life360's stronger consensus rating and higher possible upside, analysts plainly believe Life360 is more favorable than Joint Stock Company Kaspi.kz.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Joint Stock Company Kaspi.kz	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20
Life360	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55

Joint Stock Company Kaspi.kz has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market. Comparatively, Life360 has a beta of 2.63, meaning that its stock price is 163% more volatile than the broader market.

Life360 has a net margin of 28.21% compared to Joint Stock Company Kaspi.kz's net margin of 24.89%. Joint Stock Company Kaspi.kz's return on equity of 43.80% beat Life360's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Joint Stock Company Kaspi.kz	24.89%	43.80%	10.03%
Life360	28.21%	6.80%	3.65%

32.2% of Joint Stock Company Kaspi.kz shares are held by institutional investors. Comparatively, 20.0% of Life360 shares are held by institutional investors. 6.8% of Life360 shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Life360 beats Joint Stock Company Kaspi.kz on 10 of the 17 factors compared between the two stocks.

How does Life360 compare to Medpace?

Life360 (NASDAQ:LIF) and Medpace (NASDAQ:MEDP) are both business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends and profitability.

20.0% of Life360 shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 6.8% of Life360 shares are held by company insiders. Comparatively, 20.5% of Medpace shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Life360 has a beta of 2.63, meaning that its share price is 163% more volatile than the broader market. Comparatively, Medpace has a beta of 1.18, meaning that its share price is 18% more volatile than the broader market.

Life360 has a net margin of 28.21% compared to Medpace's net margin of 17.19%. Medpace's return on equity of 120.89% beat Life360's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Life360	28.21%	6.80%	3.65%
Medpace	17.19%	120.89%	24.79%

Medpace has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Life360	$489.48M	9.14	$150.83M	$1.73	31.93
Medpace	$2.53B	6.05	$451.12M	$15.91	33.71

Life360 presently has a consensus target price of $64.17, suggesting a potential upside of 16.16%. Medpace has a consensus target price of $467.08, suggesting a potential downside of 12.92%. Given Life360's stronger consensus rating and higher probable upside, research analysts clearly believe Life360 is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Life360	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55
Medpace	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, Life360 had 8 more articles in the media than Medpace. MarketBeat recorded 11 mentions for Life360 and 3 mentions for Medpace. Medpace's average media sentiment score of 0.98 beat Life360's score of 0.44 indicating that Medpace is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Life360	2 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Medpace	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Medpace beats Life360 on 9 of the 17 factors compared between the two stocks.

How does Life360 compare to Rentokil Initial?

Rentokil Initial (NYSE:RTO) and Life360 (NASDAQ:LIF) are both business services companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Rentokil Initial has higher revenue and earnings than Life360.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rentokil Initial	$6.91B	2.08	$470M	N/A	N/A
Life360	$489.48M	9.14	$150.83M	$1.73	31.93

Rentokil Initial has a beta of 0.96, suggesting that its share price is 4% less volatile than the broader market. Comparatively, Life360 has a beta of 2.63, suggesting that its share price is 163% more volatile than the broader market.

Rentokil Initial presently has a consensus target price of $34.50, suggesting a potential upside of 21.41%. Life360 has a consensus target price of $64.17, suggesting a potential upside of 16.16%. Given Rentokil Initial's higher probable upside, equities research analysts clearly believe Rentokil Initial is more favorable than Life360.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rentokil Initial	2 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.50
Life360	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55

Life360 has a net margin of 28.21% compared to Rentokil Initial's net margin of 0.00%. Life360's return on equity of 6.80% beat Rentokil Initial's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rentokil Initial	N/A	N/A	N/A
Life360	28.21%	6.80%	3.65%

In the previous week, Life360 had 11 more articles in the media than Rentokil Initial. MarketBeat recorded 11 mentions for Life360 and 0 mentions for Rentokil Initial. Life360's average media sentiment score of 0.44 beat Rentokil Initial's score of 0.00 indicating that Life360 is being referred to more favorably in the news media.

Company	Overall Sentiment
Rentokil Initial	Neutral
Life360	Neutral

9.9% of Rentokil Initial shares are owned by institutional investors. Comparatively, 20.0% of Life360 shares are owned by institutional investors. 6.8% of Life360 shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Life360 beats Rentokil Initial on 10 of the 14 factors compared between the two stocks.

How does Life360 compare to Grab?

Grab (NASDAQ:GRAB) and Life360 (NASDAQ:LIF) are both business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

Life360 has a net margin of 28.21% compared to Grab's net margin of 10.67%. Life360's return on equity of 6.80% beat Grab's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Grab	10.67%	5.79%	3.28%
Life360	28.21%	6.80%	3.65%

Grab has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market. Comparatively, Life360 has a beta of 2.63, suggesting that its share price is 163% more volatile than the broader market.

In the previous week, Grab had 2 more articles in the media than Life360. MarketBeat recorded 13 mentions for Grab and 11 mentions for Life360. Grab's average media sentiment score of 0.63 beat Life360's score of 0.44 indicating that Grab is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Grab	5 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Life360	2 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

55.5% of Grab shares are owned by institutional investors. Comparatively, 20.0% of Life360 shares are owned by institutional investors. 3.6% of Grab shares are owned by company insiders. Comparatively, 6.8% of Life360 shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Grab has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Grab, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Grab	$3.37B	4.69	$268M	$0.01	385.50
Life360	$489.48M	9.14	$150.83M	$1.73	31.93

Grab currently has a consensus price target of $6.23, suggesting a potential upside of 61.55%. Life360 has a consensus price target of $64.17, suggesting a potential upside of 16.16%. Given Grab's stronger consensus rating and higher possible upside, research analysts plainly believe Grab is more favorable than Life360.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Grab	0 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.91
Life360	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55

Summary

Grab beats Life360 on 9 of the 16 factors compared between the two stocks.

How does Life360 compare to Toast?

Toast (NYSE:TOST) and Life360 (NASDAQ:LIF) are both business services companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

Life360 has a net margin of 28.21% compared to Toast's net margin of 6.39%. Toast's return on equity of 20.86% beat Life360's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Toast	6.39%	20.86%	13.84%
Life360	28.21%	6.80%	3.65%

In the previous week, Life360 had 6 more articles in the media than Toast. MarketBeat recorded 11 mentions for Life360 and 5 mentions for Toast. Life360's average media sentiment score of 0.44 beat Toast's score of 0.42 indicating that Life360 is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Toast	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Life360	2 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

82.9% of Toast shares are held by institutional investors. Comparatively, 20.0% of Life360 shares are held by institutional investors. 10.0% of Toast shares are held by company insiders. Comparatively, 6.8% of Life360 shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Toast presently has a consensus target price of $37.62, indicating a potential upside of 33.03%. Life360 has a consensus target price of $64.17, indicating a potential upside of 16.16%. Given Toast's stronger consensus rating and higher possible upside, analysts plainly believe Toast is more favorable than Life360.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Toast	0 Sell rating(s)	8 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.78
Life360	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55

Toast has a beta of 1.76, suggesting that its stock price is 76% more volatile than the broader market. Comparatively, Life360 has a beta of 2.63, suggesting that its stock price is 163% more volatile than the broader market.

Toast has higher revenue and earnings than Life360. Life360 is trading at a lower price-to-earnings ratio than Toast, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Toast	$6.45B	2.26	$342M	$0.65	43.50
Life360	$489.48M	9.14	$150.83M	$1.73	31.93

Summary

Toast beats Life360 on 11 of the 17 factors compared between the two stocks.

Get Life360 News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LIF vs. The Competition

Export

Metric	Life360	PROTECTION Industry	Industrials Sector	NASDAQ Exchange
Market Cap	$4.47B	$3.31B	$9.78B	$12.57B
Dividend Yield	N/A	1.84%	3.53%	6.21%
P/E Ratio	31.91	21.16	25.81	24.73
Price / Sales	9.14	4.21	4,811.00	110.43
Price / Cash	N/A	27.30	27.38	36.96
Price / Book	7.90	3.42	4.62	6.54
Net Income	$150.83M	$106.44M	$791.01M	$336.74M
7 Day Performance	17.68%	1.51%	0.24%	1.34%
1 Month Performance	30.00%	-8.74%	-1.01%	0.45%
1 Year Performance	-15.34%	-20.87%	21.60%	30.94%

Life360 Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LIF Life360	4.0728 of 5 stars	$55.56 -3.5%	$64.17 +15.5%	-7.3%	$4.50B	$489.48M	32.11	600
KSPI Joint Stock Company Kaspi.kz	3.9921 of 5 stars	$89.08 +2.6%	$96.67 +8.5%	+1.5%	$16.99B	$4.29T	8.25	14,008
MEDP Medpace	2.1963 of 5 stars	$524.52 +0.9%	$467.08 -11.0%	+72.1%	$15.03B	$2.68B	33.08	6,200
RTO Rentokil Initial	3.1492 of 5 stars	$28.95 +0.2%	$34.50 +19.2%	+17.7%	$14.62B	$6.91B	N/A	63,388
GRAB Grab	4.1495 of 5 stars	$3.55 +2.7%	$6.19 +74.2%	-24.0%	$14.57B	$3.37B	355.86	12,012	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LIF) was last updated on 6/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Life360 (LIF) Competitors

LIF vs. KSPI, MEDP, RTO, GRAB, and TOST

How does Life360 compare to Joint Stock Company Kaspi.kz?

Summary

How does Life360 compare to Medpace?

Summary

How does Life360 compare to Rentokil Initial?

Summary

How does Life360 compare to Grab?

Summary

How does Life360 compare to Toast?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LIF vs. The Competition

Life360 Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Life360 (LIF) Competitors

LIF vs. KSPI, MEDP, RTO, GRAB, and TOST

How does Life360 compare to Joint Stock Company Kaspi.kz?

Which has stronger earnings and valuation, KSPI or LIF?

Does the media favor KSPI or LIF?

Do analysts recommend KSPI or LIF?

Which has more risk and volatility, KSPI or LIF?

Is KSPI or LIF more profitable?

Do institutionals and insiders have more ownership in KSPI or LIF?

Summary

How does Life360 compare to Medpace?

Do institutionals and insiders believe in LIF or MEDP?

Which has more volatility and risk, LIF or MEDP?

Is LIF or MEDP more profitable?

Which has preferable earnings and valuation, LIF or MEDP?

Do analysts rate LIF or MEDP?

Does the media refer more to LIF or MEDP?

Summary

How does Life360 compare to Rentokil Initial?

Which has preferable earnings and valuation, RTO or LIF?

Which has more volatility & risk, RTO or LIF?

Do analysts recommend RTO or LIF?

Is RTO or LIF more profitable?

Does the media favor RTO or LIF?

Do institutionals & insiders hold more shares of RTO or LIF?

Summary

How does Life360 compare to Grab?

Is GRAB or LIF more profitable?

Which has more volatility and risk, GRAB or LIF?

Does the media favor GRAB or LIF?

Do institutionals and insiders hold more shares of GRAB or LIF?

Which has stronger valuation and earnings, GRAB or LIF?

Do analysts recommend GRAB or LIF?

Summary

How does Life360 compare to Toast?

Is TOST or LIF more profitable?

Does the media refer more to TOST or LIF?

Do institutionals & insiders have more ownership in TOST or LIF?

Do analysts recommend TOST or LIF?

Which has more volatility & risk, TOST or LIF?

Which has higher valuation and earnings, TOST or LIF?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LIF vs. The Competition

Life360 Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools